Patterns of metastasis from a multicenter cohort of metastatic basal cell carcinoma.

Autor: Groover M; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Gupta N; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Granger E; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Forrester VJ; Department of Dermatology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio., Anstadt EJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Su W; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Heusinkveld L; Department of Dermatology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio., Lukens JN; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Silk AW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schoenfeld JD; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Koyfman SA; Department of Radiation Oncology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio., Vidimos AT; Department of Dermatology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio., Ruiz ES; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: esruiz@bwh.harvard.edu.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jun; Vol. 90 (6), pp. 1252-1254. Date of Electronic Publication: 2024 Feb 07.

SMAD4 loss predicts worse overall and distant metastasis-free survival in patients with resected pancreatic adenocarcinoma.

Autor: Anstadt EJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Carmona R; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Berlin E; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Yegya-Raman N; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Venigalla S; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Reddy V; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Williams GR; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Leibensperger MR; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Wojcieszynski A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Baumann BC; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Lee MK; Division of Gastrointestinal Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Plastaras JP; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Furth EE; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Mell LK; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, California, USA., Metz JM; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ben-Josef E; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Publikováno v: Cancer [Cancer] 2024 Feb 01; Vol. 130 (3), pp. 476-484. Date of Electronic Publication: 2023 Oct 12.

A multicenter real-world analysis of first-line systemic monotherapy for locally advanced basal cell carcinoma.

Autor: Groover MK; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Gupta N; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Granger E; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Murad F; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Forrester VJ; Department of Dermatology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio., Anstadt EJ; Department of Radiation Oncology, Perelman Center for Advanced Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Su W; Department of Radiation Oncology, Perelman Center for Advanced Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Heusinkveld L; Department of Dermatology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio., Lukens JN; Department of Radiation Oncology, Perelman Center for Advanced Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Silk AW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Vidimos AT; Department of Dermatology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio., Schoenfeld JD; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Koyfman SA; Department of Radiation Oncology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio., Ruiz ES; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Publikováno v: JAAD case reports [JAAD Case Rep] 2023 Oct 29; Vol. 42, pp. 69-71. Date of Electronic Publication: 2023 Oct 29 (Print Publication: 2023).

Stricter Postoperative Oropharyngeal Cancer Radiation Therapy Normal Tissue Dose Constraints Are Feasible.

Autor: Su W; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Wright CM; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Lee DY; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Kim M; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Anstadt EJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Teo BK; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Carlson DJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Lukens JN; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Eisbruch A; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Lin A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: alexander.lin2@pennmedicine.upenn.edu.

Publikováno v: Practical radiation oncology [Pract Radiat Oncol] 2022 Jul-Aug; Vol. 12 (4), pp. e282-e285. Date of Electronic Publication: 2022 Mar 15.

Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy.

Autor: Mohiuddin JJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Chu B; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Facciabene A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Poirier K; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Wang X; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA., Doucette A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Zheng C; Tara Miller Melanoma Center, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Xu W; Tara Miller Melanoma Center, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Anstadt EJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Amaravadi RK; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Karakousis GC; Division of Endocrine and Oncologic Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA., Mitchell TC; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Huang AC; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Shabason JE; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Lin A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Swisher-McClure S; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Maity A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA., Schuchter LM; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lukens JN; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Feb 01; Vol. 113 (2), pp. 162-170.